Decreased expression of miR-410-3p correlates with poor prognosis and tumorigenesis in human glioma

References

• Simon M, Hosking FJ, Marie Y, et al. Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res. 2010;16(21):5252–5259. doi:10.1158/1078-0432.CCR-10-150220847058
   PubMed Web of Science ®Google Scholar
• Zeng T, Cui D, Gao L. Glioma: an overview of current classifications, characteristics, molecular biology and target therapies. Front Biosci. 2015;20(7):1104–1115. doi:10.2741/4362
   Google Scholar
• Ohgaki H, Kleihues P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 2009;100(12):2235–2241. doi:10.1111/j.1349-7006.2009.01308.x19737147
   PubMed Web of Science ®Google Scholar
• Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011;20(14):2897–2904. doi:10.1093/hmg/ddr19221531791
   PubMed Web of Science ®Google Scholar
• Shete S, Lau CC, Houlston RS, et al. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the gliogene consortiu. Cancer Res. 2011;71(24):7568–7575. doi:10.1158/0008-5472.CAN-11-001322037877
   PubMed Web of Science ®Google Scholar
• Tsai WC, Hueng DY, Nieh S, Gao HW. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas. J Clin Pathol. 2017;70(2):162–167. doi:10.1136/jclinpath-2016-20380427451434
   PubMed Web of Science ®Google Scholar
• Liu M, Lin Y, Zhang XC, et al. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas. Lab Invest. 2017;97(11):1354–1363. doi:10.1038/labinvest.2017.7028759011
   PubMed Web of Science ®Google Scholar
• Yoon DJ, Kwan BH, Chao FC, et al. Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery. Cancer Res. 2010;70(11):4520–4527. doi:10.1158/0008-5472.CAN-09-431120460527
   PubMed Web of Science ®Google Scholar
• Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012;22(7):1243–1254. doi:10.1101/gr.132514.11122456605
   PubMed Web of Science ®Google Scholar
• Dong H, Lei J, Ding L, Wen Y, Ju H, Zhang X. MicroRNA: function, detection, and bioanalysis. Chem Rev. 2013;113(8):6207–6233. doi:10.1021/cr300362f23697835
   PubMed Web of Science ®Google Scholar
• Fu L, Shi Z, Luo G, et al. Multiple microRNAs regulate human FOXP2 gene expression by targeting sequences in its 3ʹ untranslated region. Mol Brain. 2014;7(1):71. doi:10.1186/s13041-014-0056-z25269856
   PubMedGoogle Scholar
• O’Carroll D, Schaefer A. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology. 2013;38(1):39–54. doi:10.1038/npp.2012.8722669168
   PubMed Web of Science ®Google Scholar
• Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28(5):1213–1223. doi:10.1523/JNEUROSCI.5065-07.200818234899
   PubMed Web of Science ®Google Scholar
• Lei R, Tang J, Zhuang X, et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene. 2014;33(10):1287–1296. doi:10.1038/onc.2013.6523474751
   PubMed Web of Science ®Google Scholar
• Li BS, Zuo QF, Zhao YL, et al. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene. 2015;34(20):2556–2565. doi:10.1038/onc.2014.21425043310
   PubMed Web of Science ®Google Scholar
• Zhao B, Han H, Chen J, et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 2014;342(1):43–51. doi:10.1016/j.canlet.2013.08.03023981581
   PubMed Web of Science ®Google Scholar
• Zhang YF, Yu Y, Song WZ, et al. miR-410-3p suppresses breast cancer progression by targeting snail. Oncol Rep. 2016;36(1):480–486. doi:10.3892/or.2016.482827221455
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang D, Wei A, et al. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Oncotarget. 2017;8(64):107500–107512. doi:10.18632/oncotarget.2249429296182
   PubMedGoogle Scholar
• Wen N, Wang Y, Wen L, et al. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. J Transl Med. 2014;12(1):134. doi:10.1186/1479-5876-12-13424885308
   PubMedGoogle Scholar
• Goldie SJ, Mulder KW, Tan DW, Lyons SK, Sims AH, Watt FM. FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis. Cancer Res. 2012;72(13):3424–3436. doi:10.1158/0008-5472.CAN-12-042322564525
   PubMed Web of Science ®Google Scholar
• Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005;65(12):5153–5162. doi:10.1158/0008-5472.CAN-04-378515958559
   PubMed Web of Science ®Google Scholar
• Gao L, Feng Y, Bowers R, et al. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res. 2006;66(16):7880–7888. doi:10.1158/0008-5472.CAN-06-025416912161
   PubMed Web of Science ®Google Scholar
• Daumke O, Weyand M, Chakrabarti PP, Vetter IR, Wittinghofer A. The GTPase-activating protein Rap1GAP uses a catalytic asparagine. Nature. 2004;429(6988):197–201. doi:10.1038/nature0250515141215
   PubMed Web of Science ®Google Scholar
• Du L, Subauste MC, Desevo C, et al. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One. 2012;7(6):e39167. doi:10.1371/journal.pone.003916722723956
   PubMed Web of Science ®Google Scholar
• Wang K, Li J, Guo H, et al. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis. 2012;33(11):2147–2154. doi:10.1093/carcin/bgs25922859270
   PubMed Web of Science ®Google Scholar
• Lu L, Wang J, Wu Y, Wan P, Yang G. Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling. Cancer Med. 2016;5(12):3544–3554. doi:10.1002/cam4.94627925454
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wurdinger T, Kesari S, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369–5380. doi:10.1128/MCB.00479-0818591254
   PubMed Web of Science ®Google Scholar
• Jiang J, Sun X, Wang W, et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol. 2012;299(5):3472–3477. doi:10.1007/s12032-012-0259-z
   Google Scholar
• Que T, Song Y, Liu Z, et al. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 2015;34(38):4952–4963. doi:10.1038/onc.2014.41925597410
   PubMed Web of Science ®Google Scholar
• Li M, Li J, Liu L, Li W, Yang Y, Yuan J. MicroRNA in human glioma. Cancers. 2013;5(4):1306–1331. doi:10.3390/cancers504130624202447
   PubMedGoogle Scholar
• Retta SF, Balzac F, Avolio M. Rap1: a turnabout for the crosstalk between cadherins and integrins. Eur J Cell Biol. 2006;85(3–4):283–293. doi:10.1016/j.ejcb.2005.09.00716546572
   PubMed Web of Science ®Google Scholar
• Zhang YL, Wang RC, Cheng K, Ring BZ, Su L. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 2017;14(1):90–99. doi:10.20892/j.issn.2095-3941.2016.008628443208
   PubMed Web of Science ®Google Scholar
• Verma SK, Ganesan TS, Kishore U, Parker PJ. The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A. Protein Cell. 2011;2(3):237–249. doi:10.1007/s13238-011-1028-z21468893
   PubMed Web of Science ®Google Scholar
• Xiang J, Bian C, Wang H, Huang S, Wu D. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. J Exp Clin Cancer Res. 2015;34(1):8. doi:10.1186/s13046-015-0125-x25636908
   PubMedGoogle Scholar
• Zhang T, Jiang K, Zhu X, et al. miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a. Int J Biol Sci. 2018;14(6):622–632. doi:10.7150/ijbs.2422329904277
   PubMed Web of Science ®Google Scholar